DealFlow OS
Get started free
Deal Structure Guide · Autism Therapy Center

How ABA Therapy Center Deals Are Structured in the Lower Middle Market

From SBA 7(a) loans to PE-backed equity rollovers, understand the financing frameworks, terms, and tradeoffs that define autism therapy center acquisitions between $1M and $5M in revenue.

Acquiring or selling an autism therapy center involves more complexity than a typical small business transaction. Medicaid credentialing, BCBA staffing dependencies, insurance contract transferability, and state licensure requirements all shape how deals are structured and financed. Most ABA therapy center acquisitions in the $1M–$5M revenue range close using one of three core structures: SBA 7(a) financing with a seller note, partial equity rollover with performance earnout, or all-cash acquisition by a PE-backed behavioral health platform. The right structure depends on buyer profile, practice financials, payor mix concentration, and whether the selling BCBA plans to remain involved post-close. Valuations typically range from 3.5x to 6x EBITDA, with stronger multiples awarded to centers with diversified payor contracts, retained clinical leadership, documented outcomes, and scalable systems. Understanding the deal structure before going to market — or before submitting an LOI — is one of the most important steps in protecting your interests on either side of the table.

Find Autism Therapy Center Businesses For Sale

SBA 7(a) Loan with Seller Note

The most common financing structure for independent buyers acquiring an ABA therapy center without institutional backing. The buyer secures an SBA 7(a) loan covering up to 80–85% of the purchase price, injects 10–15% equity, and negotiates a seller note (typically 5–10% of purchase price) on standby to bridge the gap. The SBA loan is amortized over 10 years, and the seller note is subordinated to the SBA lender, often deferred 24 months before interest payments begin.

SBA loan: 75–85% | Buyer equity: 10–15% | Seller note: 5–10%

Pros

  • Allows individual buyers — including BCBAs or clinical directors — to acquire without institutional equity partners
  • Lower equity injection requirement (10–15%) preserves buyer capital for working capital and post-close operations
  • Seller note signals seller confidence in the business and aligns incentives during the transition period

Cons

  • SBA lenders will scrutinize Medicaid concentration risk and billing compliance history, which can slow approval
  • Seller note must be on full standby during the SBA loan period, limiting seller liquidity at close
  • If the practice has owner-operator BCBA dependency, SBA lenders may require extended seller employment agreements as a condition of approval

Best for: Licensed BCBAs or clinical directors acquiring a single-site center with established payor contracts, clean billing records, and a seller willing to transition for 6–12 months.

Partial Equity Rollover with Performance Earnout

Common in PE-backed platform acquisitions where the acquirer wants the founding BCBA or owner-operator to retain skin in the game post-close. The seller receives 80–90% of the purchase price at close and rolls 10–20% of their equity into the acquiring platform or holdco. An earnout tied to EBITDA growth, BCBA retention, or revenue milestones over 12–36 months can add meaningful upside to the seller's total proceeds.

Cash at close: 80–90% | Equity rollover: 10–20% | Earnout: 10–20% of purchase price tied to 12–36 month milestones

Pros

  • Seller participates in upside if the platform grows and eventually exits at a higher multiple
  • Signals operational continuity to staff, families, and payors during a sensitive ownership transition
  • Reduces buyer's upfront capital requirement while aligning seller incentives with post-close performance

Cons

  • Earnout disputes are common if performance metrics aren't precisely defined with clear measurement protocols
  • Seller retains risk if platform underperforms or makes strategic decisions that hurt the center's operations
  • Medicaid credentialing re-enrollment timelines may complicate earnout measurement if revenue is disrupted post-close

Best for: Founding BCBA operators selling to a regional behavioral health platform seeking geographic expansion, where the seller has strong community relationships and clinical credibility worth preserving.

All-Cash Acquisition by PE-Backed Platform

A straightforward cash-at-close transaction funded entirely by a PE-backed behavioral health platform using its existing credit facility or equity capital. No SBA financing, no seller note, and no equity rollover — the seller receives full proceeds at closing. Common in competitive processes where multiple platforms are bidding on a high-quality center with diversified payor mix and clinical infrastructure already in place.

Cash at close: 100% | Seller note: 0% | Equity rollover: 0%

Pros

  • Maximum liquidity for the seller at close with no contingent consideration or performance risk
  • Fastest path to closing since no SBA underwriting timeline or lender approval is required
  • Attractive for sellers who want a clean exit and have no interest in remaining involved operationally

Cons

  • Typically requires the strongest financials — clean billing records, multiple credentialed BCBAs, and no Medicaid concentration issues — to qualify
  • Seller has no participation in future upside if the platform grows the practice significantly after close
  • PE buyers may impose aggressive integration timelines, brand changes, or clinical staffing decisions that disrupt culture

Best for: High-quality multi-BCBA ABA centers with $2M–$5M in revenue, diversified payor mix, and a seller seeking a clean exit with no ongoing operational involvement.

Sample Deal Structures

Individual BCBA Buyer Acquiring a Single-Site Center via SBA Financing

$2,100,000

SBA 7(a) loan: $1,680,000 (80%) | Buyer equity injection: $210,000 (10%) | Seller note on standby: $210,000 (10%)

SBA loan at 7.5% interest over 10 years with monthly P&I payments of approximately $19,900. Seller note deferred 24 months, then amortized over 3 years at 6% interest. Seller remains employed as clinical director for 12 months at $110,000 annual salary. Earnout of up to $150,000 tied to BCBA retention and revenue growth in year one.

PE-Backed Behavioral Health Platform Acquiring a Two-Site ABA Operator

$4,800,000

Cash at close: $4,320,000 (90%) | Equity rollover into platform holdco: $480,000 (10%)

Seller rolls 10% equity into the acquiring platform at a pre-agreed valuation, with a 4-year vesting schedule tied to continued clinical leadership. No earnout. Seller remains as Regional Clinical Director for 18 months at market-rate compensation. Medicaid credentialing re-enrollment initiated by platform's compliance team 60 days prior to close. Non-compete of 5 years within 30-mile radius.

Husband-and-Wife Operator Selling to Strategic Acquirer with Earnout

$3,400,000 base plus up to $500,000 earnout

Cash at close: $3,060,000 (90% of base) | Seller note: $340,000 (10% of base) | Earnout: up to $500,000 over 24 months

Earnout measured on EBITDA targets of $650,000 in year one and $750,000 in year two, paid semi-annually. Seller note at 5.5% interest, 5-year amortization, not on standby. Both owners transition out of clinical roles within 6 months, replaced by promoted internal BCBA. Employment agreements with all BCBAs extended to 2-year terms as a condition of close. Insurance contracts assigned with payor consent secured pre-close.

Negotiation Tips for Autism Therapy Center Deals

  • 1Push for explicit Medicaid credentialing representations and warranties in the purchase agreement — if the buyer inherits any prior billing irregularities or overpayment demands, those liabilities can materially erode deal economics post-close.
  • 2Define earnout metrics with extreme precision: specify whether EBITDA is calculated pre- or post-management fees, whether new BCBA hiring costs are included, and exactly how Medicaid rate changes during the earnout period are treated.
  • 3Negotiate a working capital peg tied to authorization hours and billing cycle timing — ABA centers with high Medicaid revenue often have 45–90 day collection cycles that create cash flow gaps for buyers immediately post-close.
  • 4If the seller is the only credentialed BCBA, require a supervised credentialing plan for at least one additional BCBA as a closing condition — this protects both parties from a clinical staffing disruption that could trigger payor audits or service interruptions.
  • 5Include a client census warranty that guarantees a minimum number of active clients with authorized hours as of the closing date, with a purchase price adjustment mechanism if the census drops materially between LOI and close.
  • 6For SBA-financed deals, negotiate the seller's transition employment agreement before the LOI is signed — SBA lenders may require it as a loan condition, and having it agreed in principle prevents last-minute leverage shifts late in the process.

Find Autism Therapy Center Businesses For Sale

Pre-screened targets ready for your deal structure — free to join.

Get Deal Flow

Frequently Asked Questions

What is the typical purchase price multiple for an autism therapy center in the lower middle market?

Most ABA therapy centers with $1M–$5M in revenue trade at 3.5x to 6x EBITDA. Centers at the lower end of the range typically have high Medicaid concentration, single-BCBA dependency, or billing compliance issues. Centers commanding 5x–6x multiples generally have diversified payor mix, multiple credentialed BCBAs with employment agreements, documented clinical outcomes, and scalable operational systems. PE-backed strategic acquirers will pay at the top of this range for quality assets; individual SBA buyers typically close at 3.5x–4.5x.

Can an autism therapy center acquisition be financed with an SBA 7(a) loan?

Yes, ABA therapy centers are eligible for SBA 7(a) financing, and this is the most common structure for individual buyers. The SBA will underwrite the deal based on the center's historical cash flow, payor mix stability, and the buyer's creditworthiness and healthcare operations experience. SBA lenders with behavioral health lending experience will scrutinize Medicaid concentration risk and billing compliance history. Buyers should expect the lender to require a seller transition period and may ask for a seller note on standby as a condition of approval.

How are earnouts typically structured in ABA therapy center acquisitions?

Earnouts in ABA therapy deals are most commonly tied to EBITDA, revenue, or specific operational milestones like BCBA retention or client census growth over a 12–36 month period. The earnout typically represents 10–20% of total deal value and is paid quarterly or semi-annually based on audited financials. The most common disputes arise from disagreements over how new hiring costs, management fees from the acquirer, or Medicaid rate changes are treated in the earnout calculation. Both parties benefit from defining these terms with surgical precision in the purchase agreement.

What happens to Medicaid credentialing when an autism therapy center is sold?

This is one of the most operationally critical issues in any ABA therapy acquisition. Medicaid provider agreements are not automatically assignable — the new ownership entity must re-enroll with the state Medicaid program, which can take 60–180 days depending on the state. During this period, the practice may experience revenue disruption if not carefully managed. Experienced buyers and their legal counsel will initiate the re-enrollment process as early as 60–90 days prior to the anticipated close date to minimize gaps. Some states allow a change-of-ownership exception that permits continued billing under the existing NPI during the transition window.

What is a seller note and why is it common in ABA therapy center deals?

A seller note is a form of financing where the seller accepts a portion of the purchase price as a deferred payment, essentially acting as a lender to the buyer. In ABA therapy center deals using SBA financing, the seller note — typically 5–10% of the purchase price — is required to be on standby, meaning the seller cannot receive payments until the SBA loan is fully repaid or a specified period has passed. Seller notes signal the seller's confidence in the business and are viewed positively by SBA lenders. For sellers, they provide a potential income stream at a negotiated interest rate, typically 5–7%, over 3–5 years.

How does BCBA staffing dependency affect deal structure?

If the selling owner is the sole or primary BCBA providing direct clinical supervision, most buyers — and SBA lenders — will require structural protections built into the deal. These typically include a 12–18 month employment or consulting agreement for the departing BCBA, a credentialing plan for at least one additional BCBA before close, and a purchase price adjustment clause if key clinical staff depart before or shortly after closing. For PE-backed acquirers, BCBA dependency is often a valuation discount factor that pushes the multiple toward the lower end of the range. Sellers who proactively build clinical depth before going to market consistently achieve better outcomes.

More Autism Therapy Center Guides

Acquire a Autism Therapy Center Business →Valuation Guide →SBA Loan Guide →LOI Template →Due Diligence →

More Deal Structure Guides

Auto Detailing →Auto Parts Distributor →Auto Repair →Auto Transport Brokerage →AV Installation & Integration →Background Screening Company →Bakery →Balloon & Party Decor →Browse all deal structure guides →

Start Finding Autism Therapy Center Deals Today — Free to Join

Find the right target, structure the deal, and close with confidence.

Create your free account

No credit card required

For Buyers

For Sellers

Free Tools

Platform

DealFlow OS
© 2026 DealFlow OSPrivacy PolicyTerms of Service